Health News

Knowledge Management At The Early Drug Development Summit

Date: Oct-17-2012
"Most of the major pharma companies are now engaging with QbD...many in the industry fail to understand how big a change in culture and practices it represents. It may be difficult at the onset for the initial development projects, but ultimately the pay-off will be great." (Huw Kidwell, 'Quality by Design - the new manufacturing paradigm', 31/05/11) We're pleased to announce that Andreas Schneider, Vice President Life Science Alliances, Roche, will be speaking at the Early Drug Development Summit, 3rd - 4th December 2012 at the Hotel Palace Berlin, Germany...

Study Reveals Vegetable-Derived Compounds Effective In Treating Triple-Negative Breast Cancer

Date: Oct-17-2012
A new compound created from a rich source in vegetables including broccoli and brussel sprouts has been developed to combat triple-negative breast cancer (TNBC). This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Chicago, Ill., on Oct. 14 â�" 18, during Breast Cancer Awareness Month. TNBC accounts for approximately 15-20 percent of all breast cancer cases in the U.S...

Novel Chewing Gum Formulation Helps Prevent Motion Sickness

Date: Oct-17-2012
A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild circumstances and 66 percent are affected in more severe conditions. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 - 18, an international event anticipating more than 8,000 attendees. Lead researcher Mohsen Sadatrezaei of RoshaDarou Co...

Antibiotic Resistance Diagnosed Much Faster With New Tests

Date: Oct-17-2012
Researchers who developed two ultra-rapid new tests, designed for worldwide use, say they dramatically speed up the diagnosis of antibiotic resistant infections and will improve our ability to control antibiotic resistance, which is emerging at an alarming rate globally among a number of bacterial species. The team, from INSERM, the National Institute of Health and Medical Research in France, write about their work in two international reviews that were published in September: Emerging Infectious Diseases and The Journal of Clinical Microbiology...

Early Diagnosis And Treatment Offered By New Tools For Alzheimer's

Date: Oct-17-2012
Curtailing the imminent rise in Alzheimer's disease (AD) will require early, accurate diagnostic tests and treatments, and researchers are closer to achieving these two goals. New findings in medical imaging, molecular analysis of neurological diseases, and development of treatments using mouse models were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health. AD is the most common cause of dementia and currently affects 5 million people in the United States...

Research Shows Exercise As Key In Reducing Body Fat While Preserving Muscle

Date: Oct-17-2012
Exercise and healthy eating reduce body fat and preserve muscle in adults better than diet alone, according to a study funded and conducted by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. The study was recently published online in Obesity and will be in a future print edition. NIDDK senior investigator Kevin Hall, Ph.D., analyzed the individual effects of daily strenuous exercise and a restricted diet by examining data from 11 participants from the reality television program "The Biggest Loser...

How Expanding Waistlines May Contribute To Cancer

Date: Oct-17-2012
Fat progenitor cells may contribute to cancer growth by fortifying the vessels that provide needed blood to tumors, according to preclinical research findings by investigators at The University of Texas Health Science Center at Houston (UTHealth). The results were reported in Cancer Research, a journal of the American Association for Cancer Research. Studies of groups of people have demonstrated a link between obesity and certain cancers; however, the physiological causes have not been identified. The World Health Organization reports that in 2008 there were more than 1...

VeriStrat Predicts Response But Not Survival Benefit From Erlotinib

Date: Oct-17-2012
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients...

First Analysis Of IASLC Malignant Pleural Mesothelioma Database

Date: Oct-17-2012
The International Mesothelioma Interest Group (IMIG) staging system has been widely used, however, widespread concerns exist about the validity of the current malignant pleural mesothelioma (MPM) staging system. Concerns include that the system is derived from analysis of small, retrospective surgical series; it can be difficult to apply to clinical staging; and uses descriptors for lymph node involvement, which may not be relevant to MPM...

Non-Small Cell Lung Cancer Patients 65 And Older Should Be Considered For Therapy

Date: Oct-17-2012
Until there are more validated biomarkers to direct treatment decisions, many physicians use patient age to decide what therapy to give their patients. Literature data report that older patients often go undertreated because of concerns for limited tolerance to toxic therapies. A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, says that fit elderly non-small cell lung cancer (NSCLC) patients should be considered for salvage targeted therapy...